Oblique Therapeutics
Hans-Peter has +20 years of experience in Investment Banking, Private Banking and Asset Management. Hans-Peter has held senior positions at Swedbank Markets, UBS AG, Danske bank and Söderberg & Partners. Hans-Peter has been involved as a board member in Swedish and international companies in Finance and Life Science such as Ancoria Insurance Public Ltd and Irlab Therapuetics Ab.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Oblique Therapeutics
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.